BBLG Q1 2023 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$4M

EPS (Diluted)

$-55.20

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$44,764

Balance Sheet

Total Assets

$7M

Total Liabilities

$4M

Stockholders' Equity

$3M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$689,499	-356.6%
Net Income	-$4M	-$689,499	-438.1%